The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
Open accessAbstract
Toxicity has been estimated to be responsible for the attrition of approximately one-third of drug candidates and is a major contributor to the high cost of drug development, particularly when not recognized until late in clinical trials or post-marketing. The causes of drug toxicity can be classified in several ways and include mechanism-based (on-target) toxicity, immune hypersensitivity, off-target toxicity, and bioactivation/covalent modification. In addition, idiosyncratic responses are rare but can be one of the most problematic issues; several hypotheses for these have been advanced. Although covalent binding of drugs to proteins was described almost 40 years ago, the significance to toxicity has been difficult to establish; recent literature in this field is considered. The development of more useful biomarkers and short-term assays for rapid screening of drug toxicity early in the drug discovery/development process is a major goal, and some progress has been made using "omics" approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. I. ROLE OF DRUG METABOLISM
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29663-x · Cited by 1,498
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,204
Acetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
Delayed Drug Hypersensitivity Reactions
Pichler, W. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00012 · Cited by 735
Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., & Baillie, T. A. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034170b · Cited by 706
STUDIES ON THE SENSITIZATION OF ANIMALS WITH SIMPLE CHEMICAL COMPOUNDS
Landsteiner, K., & Jacobs, J. (1935) · Journal of Experimental Medicine · doi:10.1084/jem.61.5.643 · Cited by 700
Vaidya, V. S., Ozer, J. S., Dieterle, F., Collings, F. B., Ramirez, V., Troth, S., Muniappa, N., Thudium, D., Gerhold, D., Holder, D. J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1623 · Cited by 660
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups
Kalgutkar, A., Gardner, I., Obach, R., Shaffer, C., Callegari, E., Henne, K., Mutlib, A., Dalvie, D., Lee, J., Nakai, Y., et al. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021799 · Cited by 616
Friendly and dangerous signals: is the tissue in control?
Matzinger, P. (2007) · Nature Immunology · doi:10.1038/ni0107-11 · Cited by 532
Wysowski, D. K., & Swartz, L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1363 · Cited by 471
THE ROLE OF METABOLIC ACTIVATION IN DRUG-INDUCED HEPATOTOXICITY
Park, B. K., Kitteringham, N. R., Maggs, J. L., Pirmohamed, M., & Williams, D. P. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100058 · Cited by 453
Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System
Sanderson, D. M., & Earnshaw, C. G. (1991) · Human & Experimental Toxicology · doi:10.1177/096032719101000405 · Cited by 368
Kindmark, A., Jawaid, A., Harbron, C. G., Barratt, B. J., Bengtsson, O. F., Andersson, T. B., Carlsson, S., Cederbrant, K. E., Gibson, N. J., Armstrong, M., et al. (2008) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500458 · Cited by 367
Dieterle, F., Perentes, E., Cordier, A., Roth, D. R., Verdes, P., Grenet, O., Pantano, S., Moulin, P., Wahl, D., Mahl, A., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1622 · Cited by 334
Elucidating mechanisms of drug-induced toxicity
Liebler, D. C., & Guengerich, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1720 · Cited by 323
Self-citationRole of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Miller, E. C., & MILLER, J. A. (1947) · Cancer Research · Cited by 318
Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000180q · Cited by 311
Uetrecht, J. P. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980249i · Cited by 304
Idiosyncratic Drug Reactions: Current Understanding
Uetrecht, J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105150 · Cited by 304
Tirmenstein, M. A., & Nelson, S. D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81731-8 · Cited by 298
Mechanisms of Immune-Mediated Liver Injury
Adams, D. H., Ju, C., Ramaiah, S. K., Uetrecht, J., & Jaeschke, H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq009 · Cited by 298
Idiosyncratic Drug Reactions: Past, Present, and Future
Uetrecht, J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700186p · Cited by 257
Knowledge-Based Expert Systems for Toxicity and Metabolism Prediction: DEREK, StAR and METEOR
Greene, N., Judson, P. N., Langowski, J. J., & Marchant, C. A. (1999) · SAR and QSAR in Environmental Research · doi:10.1080/10629369908039182 · Cited by 250
Mitochondrial abnormalities—A link to idiosyncratic drug hepatotoxicity?
Boelsterli, U. A., & Lim, P. L. K. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.013 · Cited by 232
Applying Mechanisms of Chemical Toxicity to Predict Drug Safety
Guengerich, F. P., & MacDonald, J. S. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600260a · Cited by 231
Self-citationIsoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat
Nelson, S. D., Mitchell, J. R., Timbrell, J. A., Snodgrass, W. R., & Corcoran, G. B. (1976) · Science · doi:10.1126/science.7838 · Cited by 226
Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., & Fielden, M. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032748 · Cited by 225
Obach, R. S., Kalgutkar, A. S., Soglia, J. R., & Zhao, S. X. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800161s · Cited by 214
Bakke, O. M., Manocchia, M., de Abajo, F., Kaitin, K. I., & Lasagna, L. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90078-0 · Cited by 208
Bourdi, M., Larrey, D., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F. P., & Beaune, P. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114660 · Cited by 207
Self-citationOzer, J. S., Dieterle, F., Troth, S., Perentes, E., Cordier, A., Verdes, P., Staedtler, F., Mahl, A., Grenet, O., Roth, D. R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1627 · Cited by 203
Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury
Yu, Y., Jin, H., Holder, D., Ozer, J. S., Villarreal, S., Shughrue, P., Shi, S., Figueroa, D. J., Clouse, H., Su, M., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1624 · Cited by 185
Paracelsus: Herald of Modern Toxicology
Borzelleca, J. F. (2000) · Toxicological Sciences · doi:10.1093/toxsci/53.1.2 · Cited by 171
Developing Structure−Activity Relationships for the Prediction of Hepatotoxicity
Greene, N., Fisk, L., Naven, R. T., Note, R. R., Patel, M. L., & Pelletier, D. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1000865 · Cited by 171
Ganter, B., Snyder, R. D., Halbert, D. N., & Lee, M. D. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1025 · Cited by 168
Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo.
Timbrell, J. A., Mitchell, J. R., Snodgrass, W. R., & Nelson, S. D. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32069-0 · Cited by 161
Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor
Ganey, P. E., Luyendyk, J. P., Maddox, J. F., & Roth, R. A. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.002 · Cited by 150
In Vitro Metabolism of Tolcapone to Reactive Intermediates: Relevance to Tolcapone Liver Toxicity
Smith, K. S., Smith, P. L., Heady, T. N., Trugman, J. M., Harman, W. D., & Macdonald, T. L. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025569n · Cited by 147
Johnson, T. E., Zhang, X. D., Bleicher, K. B., Dysart, G. R., Loughlin, A. F., Schaefer, W. H., & Umbenhauer, D. R. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.010 · Cited by 144
Bauman, J. N., Kelly, J. M., Tripathy, S., Zhao, S. X., Lam, W. W., Kalgutkar, A. S. S., & Obach, R. S. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800407w · Cited by 140
Reid, J. M., Kuffel, M. J., Miller, J. K., Ríos, R., & Ames, M. M. (1999) · PubMed · Cited by 133
Drug-induced liver injury: Hy’s rule revisited
BJORNSSON, E. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.012 · Cited by 128
Bansal, S., Liu, C., Sepuri, N. B. V., Anandatheerthavarada, H. K., Selvaraj, V., Hoek, J. B., Milne, G. L., Guengerich, F. P., & Avadhani, N. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121822 · Cited by 125
Self-citationImmune-Mediated Adverse Drug Reactions
Uetrecht, J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800389u · Cited by 124
Masubuchi, N., Makino, C., & Murayama, N. (2007) · Chemical Research in Toxicology · doi:10.1021/tx060234h · Cited by 123
Animal models of idiosyncratic drug reactions
Shenton, J. M., Chen, J., & Uetrecht, J. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.001 · Cited by 116
Comparative Pharmacokinetic Profile of Two Imidazopyridine Drugs: Zolpidem and Alpidem
Durand, A., Thenot, J. P., Bianchetti, G., & Morselli, P. L. (1992) · Drug Metabolism Reviews · doi:10.3109/03602539208996294 · Cited by 115
Gan, J., Ruan, Q., He, B., Zhu, M., Shyu, W. C., & Humphreys, W. G. (2009) · Chemical Research in Toxicology · doi:10.1021/tx800368n · Cited by 102
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: Issues of safety
Bakke, O. M., Wardell, W. M., & Lasagna, L. C. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.78 · Cited by 99
Mechanisms of Pathogenesis in Drug Hepatotoxicity Putting the Stress on Mitochondria
Jones, D. P., Lemasters, J. J., Han, D., Boelsterli, U. A., & Kaplowitz, N. (2010) · Molecular Interventions · doi:10.1124/mi.10.2.7 · Cited by 93
Dansette, P. M., Bonierbale, E., Minoletti, C., Beaune, P. H., Pessayre, D., & Mansuy, D. (1998) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189993 · Cited by 92
Amacher, D. E. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.011 · Cited by 91
Autoantibodies against Cytochromes P450: Role in Human Diseases
Beaune, P. H., Pessayre, D., Dansette, P. M., Mansuy, D., & Manns, M. P. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60175-1 · Cited by 90
N-Deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes
Rodríguez, R. L., & Acosta, D. (1997) · Toxicology · doi:10.1016/s0300-483x(96)03560-3 · Cited by 88
Qiu, Y., Burlingame, A. L., & Benet, L. Z. (1998) · PubMed · Cited by 81
Roberts, S., Price, V. F., & Jollow, D. J. (1990) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(90)90181-s · Cited by 68
Cellular mechanisms of T cell mediated drug hypersensitivity
Gerber, B. O., & Pichler, W. J. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.016 · Cited by 67
Berson, A., Wolf, C., Chachaty, C., Fisch, C., Fau, D., Eugene, D., Loeper, J., Gauthier, J.-C., Beaune, P. H., & Pompon, D. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38106-1 · Cited by 65
Streeter, A. J., Bjorge, S. M., Axworthy, D. B., Nelson, S. D., & Baillie, T. A. (1984) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07764-5 · Cited by 58
Lee, Y. H., Chung, M. C. M., Lin, Q., & Boelsterli, U. A. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.025 · Cited by 55
Luyendyk, J. P., Shores, K. C., Ganey, P. E., & Roth, R. A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.220 · Cited by 40
Metabolic activation of the tricyclic antidepressant amineptine—I
Genève, J., Larrey, D. G., Lettéron, P., Descatoire, V., Tinel, M., Amouyal, G., & Pessayre, D. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90289-9 · Cited by 35
Obach, R. S., & Dalvie, D. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010173 · Cited by 35
Rosuvastatin: an independent analysis of risks and benefits.
Zipes, D. P., Zvaifler, N. J., Glassock, R. J., Gilman, S., Muñoz, Á., Gogolak, V., Gordis, L., Dedon, P. C., Guengerich, F. P., Wasserman, S. I., et al. (2006) · PubMed Central · Cited by 19
Self-citation
Cited by
ProTox 3.0: a webserver for the prediction of toxicity of chemicals
Banerjee, P., Kemmler, E., Dunkel, M., & Preissner, R. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae303 · Cited by 1,601
Machine Learning in Drug Discovery: A Review
Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 792
Surface Plasmon Resonance (SPR) Biosensors in Pharmaceutical Analysis
Olaru, A., Bala, C., Jaffrezic-Renault, N., & Aboul-Enein, H. Y. (2015) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2014.881250 · Cited by 400
Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347
“In the course of development of fresh drugs, pre-clinical and clinical toxicity accounts for the reduction of roughly 33% of leading moieties [186].”
Artificial intelligence for drug discovery: Resources, methods, and applications
Chen, W., Liu, X., Zhang, S., & Chen, S. (2023) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2023.02.019 · Cited by 273
Metadata
- Authors
- Guengerich, F. P.
- Venue
- Drug Metabolism and Pharmacokinetics
- Published
- 2011
- Volume
- 26
- Issue
- 1
- Pages
- 3-14
- ISSN
- 1347-4367 (ISSN-L)
- OpenAlex
- W2146402650
- Cited by
- 387
- References
- 69
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.